Prelude Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-45,148
| Closed | -$506K | – | 1815 |
|
|
2017
Q3 | $506K | Buy |
45,148
+39,027
| +638% | +$437K | 0.05% | 333 |
|
|
2017
Q2 | $67K | Sell |
6,121
-18,551
| -75% | -$203K | 0.01% | 817 |
|
|
2017
Q1 | $242K | Buy |
24,672
+17,527
| +245% | +$172K | 0.02% | 462 |
|
|
2016
Q4 | $77K | Sell |
7,145
-12,755
| -64% | -$137K | 0.01% | 871 |
|
|
2016
Q3 | $204K | Buy |
19,900
+14,300
| +255% | +$147K | 0.02% | 507 |
|
|
2016
Q2 | $73K | Sell |
5,600
-400
| -7% | -$5.21K | 0.01% | 824 |
|
|
2016
Q1 | $66K | Sell |
6,000
-14,000
| -70% | -$154K | 0.01% | 824 |
|
|
2015
Q4 | $184K | Buy |
20,000
+11,300
| +130% | +$104K | 0.03% | 563 |
|
|
2015
Q3 | $60K | Buy |
8,700
+2,400
| +38% | +$16.6K | 0.01% | 933 |
|
|
2015
Q2 | $62K | Buy |
6,300
+5,000
| +385% | +$49.2K | 0.01% | 1005 |
|
|
2015
Q1 | $12K | Buy |
+1,300
| New | +$12K | ﹤0.01% | 1733 |
|
|
2014
Q4 | – | Sell |
-8,816
| Closed | -$61K | – | 2190 |
|
|
2014
Q3 | $61K | Buy |
8,816
+2,916
| +49% | +$20.2K | 0.01% | 1224 |
|
|
2014
Q2 | $31K | Buy |
+5,900
| New | +$31K | ﹤0.01% | 1479 |
|